Searched for
ORAL ELECTROLYTES MARKET
ORS sales melt in March after govt's stricter labelling normsIndia’s oral rehydration solution (ORS) market has declined after regulatory action restricted the labelling of sugary drinks as ORS, affec...- Best medicine for volatile times: Don’t buy a stock, buy a business; 5 pharma stocks with upside potential of up to 43%Don’t buy a stock, buy a business, says our headline. It’s not as easy as it sounds. But it’s not too difficult either. While there are sev...
- These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsThe Indian markets on Wednesday rose in lockstep with global peers that reacted, among other things, to the possibility of an end to the Ru...
- FSSAI asks states to remove fruit-based beverages, other drinks being sold under ORS brand from marketsFSSAI has asked states and Union Territories to immediately remove fruit-based drinks, ready-to-serve beverages, electrolyte drinks and ene...
- Delhi HC refuses to allow firm to sell existing beverages stock with ORS labellingThe Delhi High Court refused to allow a company to sell its existing stock of electrolyte beverages labeled ORSL, citing misbranding and pu...
- Delhi High Court upholds FSSAI ban on sale of 'mislabelled' ORS beveragesThe Delhi High Court has backed the FSSAI's decision to ban the use of 'ORS' labelling on fruit-based drinks. The court cited serious publi...
- MNC pharma companies: Time to take a re-look? 8 pharma stocks, 5 with an upside of up to 34%Some time back an MNC pharma firm announced the divestment of one of its businesses in India. Another sold one of its plants. Now, with the...
- Mercury soars, and so do sales of rehydration drinks in IndiaIndia is experiencing a surge in demand for dehydration-preventing drinks due to the intense heatwave. Electral sales have jumped 27% in Ma...
- MNC pharma: Time to re-look at them without bias? 8 MNC pharma stocks, 5 with an upside potential of 15 to 52%While they still trade at premium valuations, they have not created much wealth for shareholders in recent times. The age-old theory that h...
- As monsoon takes hold, anti-infective, respiratory drugs' demand surgesMonsoon led to a surge in demand for respiratory, anti-infective, and anti-malarial products. The respiratory market saw a notable increase...
- Sales of Electral jump 26% in hottest April on recordIndia's pharma market took a dip in March after poor sales of respiratory and anti-infective therapies dropped post-winter. April saw the m...
- Heatwave ignites surge in chronic therapy demandRising temperatures across various regions of India are driving increased demand for medications aimed at managing chronic conditions. This...
- Thank the late monsoon for your reduced visits to the pharmacyTypically, the onset of the monsoon season in June leads to an increase in viral infections, fevers, and vector-borne diseases, thereby boo...
- Maharashtra cancels Johnson & Johnson's manufacturing licence for baby powderThe FDA had earlier issued a show-cause notice to the US pharma, medical devices and consumer goods multinational, seeking to know why acti...
- Strides gets USFDA nod to market laxative drug in USThe product will be manufactured at Strides' facility in Bengaluru and will be marketed by Strides Pharma in the US market.
- Strides Arcolab gets USFDA nod for bowel-cleansing medicineThe approval of the oral solution is for strength of 420 grams of Glycol 3350, 11.2 grams of sodium chloride, 5.72 grams of sodium bicarbon...
- Johnson and Johnson acquires energy drink brand from Bangalore based Jagdale industriesUnder the agreement Jagdale industries will provide transition services in the area of manufacturing, detailing and distribution of ORSL.
Load More
